World Library  
Flag as Inappropriate
Email this Article

Etoperidone

Article Id: WHEBN0005796971
Reproduction Date:

Title: Etoperidone  
Author: World Heritage Encyclopedia
Language: English
Subject: Aripiprazole, Serotonin antagonist and reuptake inhibitor, Minaprine, Diclofensine, Brofaromine
Collection: Chloroarenes, Lactams, Organochlorides, Piperazines, Triazoles, Ureas
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Etoperidone

Etoperidone
Systematic (IUPAC) name
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]
propyl]-4,5-diethyl-1,2,4-triazol-3-one
Clinical data
Legal status
  • (Prescription only)
Routes of
administration
Oral
Identifiers
CAS Registry Number  Y
ATC code N06
PubChem CID:
ChemSpider  Y
UNII  Y
ChEMBL  N
Synonyms ST-1191
Chemical data
Formula C19H28ClN5O
Molecular mass 377.911 g/mol
 N   

Etoperidone (Axiomin, Centren, Depracer, Etonin, Etoran, Staff, Tropene), also known as clopradone and triazolinone, is an antidepressant of the phenylpiperazine class which was introduced in Europe in 1977.[1][2] It acts primarily as an antagonist of several receptors in the following order of potency: 5-HT2A receptor (36 nM) > α1-adrenergic receptor (38 nM) > 5-HT1A receptor (85 nM) > α2-adrenergic receptor (570 nM);[3] it has only very weak or negligible affinity for blocking the following receptors: D2 receptor (2,300 nM) > H1 receptor (3,100 nM) > mACh receptors (>35,000 nM).[3] In addition to its receptor blockade, etoperidone also has weak affinity for the monoamine transporters as well: serotonin transporter (890 nM) > norepinephrine transporter (20,000 nM) > dopamine transporter (52,000 nM).[4]

See also

References

  1. ^ C. R Ganellin; D. J Triggle; F.. Macdonald (1997). Dictionary of pharmacological agents. CRC Press. p. 859.  
  2. ^ Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 421.  
  3. ^ a b Cusack B, Nelson A, Richelson E. (19941). "Binding of Antidepressants to Human Brain Receptors: Focus on Newer Generation Compounds.". Psychopharmacology (Berl). 114 (4): 559–565.  
  4. ^ Tatsumi M, Groshan K, Blakely RD, Richelson E. (1997). "Pharmacological Profile of Antidepressants and Related Compounds at Human Monoamine Transporters.". Eur J Pharmacol. 340 (2-3): 249–258.  



This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.